494 related articles for article (PubMed ID: 17182132)
41. Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups.
Manes A; Palazzini M; Leci E; Bacchi Reggiani ML; Branzi A; Galiè N
Eur Heart J; 2014 Mar; 35(11):716-24. PubMed ID: 23455361
[TBL] [Abstract][Full Text] [Related]
42. Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry.
Chazova IE; Arkhipova OA; Martynyuk TV
Ter Arkh; 2019 Mar; 91(1):24-31. PubMed ID: 31090367
[TBL] [Abstract][Full Text] [Related]
43. Iron deficiency in pulmonary arterial hypertension associated with congenital heart disease.
Yu X; Zhang Y; Luo Q; Liu Z; Zhao Z; Zhao Q; Gao L; Jin Q; Yan L
Scand Cardiovasc J; 2018 Dec; 52(6):378-382. PubMed ID: 30632395
[TBL] [Abstract][Full Text] [Related]
44. Pulmonary hypertension after shunt closure in patients with simple congenital heart defects.
Lammers AE; Bauer LJ; Diller GP; Helm PC; Abdul-Khaliq H; Bauer UMM; Baumgartner H;
Int J Cardiol; 2020 Jun; 308():28-32. PubMed ID: 31926641
[TBL] [Abstract][Full Text] [Related]
45. Efficacy of bosentan in a small cohort of adult patients with pulmonary arterial hypertension related to congenital heart disease.
Benza RL; Rayburn BK; Tallaj JA; Coffey CS; Pinderski LJ; Pamoukian SV; Bourge RC
Chest; 2006 Apr; 129(4):1009-15. PubMed ID: 16608951
[TBL] [Abstract][Full Text] [Related]
46. Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.
D'Alto M; Romeo E; Argiento P; Sarubbi B; Santoro G; Grimaldi N; Correra A; Scognamiglio G; Russo MG; Calabrò R
Int J Cardiol; 2012 Mar; 155(3):378-82. PubMed ID: 21081251
[TBL] [Abstract][Full Text] [Related]
47. Pulmonary Hypertension and Congenital Heart Disease.
Roth TS; Aboulhosn JA
Cardiol Clin; 2016 Aug; 34(3):391-400. PubMed ID: 27443136
[TBL] [Abstract][Full Text] [Related]
48. Contemporary survival of patients with pulmonary arterial hypertension and congenital systemic to pulmonary shunts.
Vijarnsorn C; Durongpisitkul K; Chungsomprasong P; Bositthipichet D; Ketsara S; Titaram Y; Chanthong P; Kanjanauthai S; Soongswang J
PLoS One; 2018; 13(4):e0195092. PubMed ID: 29664959
[TBL] [Abstract][Full Text] [Related]
49. RV stroke work in children with pulmonary arterial hypertension: estimation based on invasive haemodynamic assessment and correlation with outcomes.
Di Maria MV; Younoszai AK; Mertens L; Landeck BF; Ivy DD; Hunter KS; Friedberg MK
Heart; 2014 Sep; 100(17):1342-7. PubMed ID: 24780910
[TBL] [Abstract][Full Text] [Related]
50. Unidirectional valved patch closure of ventricular septal defects with severe pulmonary arterial hypertension: hemodynamic outcomes.
Talwar S; Keshri VK; Choudhary SK; Gupta SK; Ramakrishnan S; Saxena A; Kothari SS; Juneja R; Kumar G; Airan B
J Thorac Cardiovasc Surg; 2014 Dec; 148(6):2570-5. PubMed ID: 24332111
[TBL] [Abstract][Full Text] [Related]
51. Changing demographics of pulmonary arterial hypertension in congenital heart disease.
Mulder BJ
Eur Respir Rev; 2010 Dec; 19(118):308-13. PubMed ID: 21119189
[TBL] [Abstract][Full Text] [Related]
52. Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1.
Li X; Qiu J; Pan M; Zheng D; Su Y; Wei M; Kong X; Sun W; Zhu J
Int J Clin Exp Pathol; 2015; 8(9):10743-51. PubMed ID: 26617785
[TBL] [Abstract][Full Text] [Related]
53. Prevalence of elevated pulmonary arterial pressures measured by echocardiography in a multicenter study of patients with systemic sclerosis.
Pope JE; Lee P; Baron M; Dunne J; Smith D; Docherty PS; Bookman A; Abu-Hakima M
J Rheumatol; 2005 Jul; 32(7):1273-8. PubMed ID: 15996064
[TBL] [Abstract][Full Text] [Related]
54. Clinical significance of dynamic pulmonary vascular resistance in two populations at risk of pulmonary arterial hypertension.
Gabriels C; Lancellotti P; Van De Bruaene A; Voilliot D; De Meester P; Buys R; Delcroix M; Budts W
Eur Heart J Cardiovasc Imaging; 2015 May; 16(5):564-70. PubMed ID: 25525064
[TBL] [Abstract][Full Text] [Related]
55. [A cross-sectional study of pulmonary arterial hypertension in congenital heart disease by right heart catheterization].
Li W; Sun Y; Pang K; Wang H; Yang T; Gu Q; Zhao Z; Xiong C; Ni X; Liu Z; He J
Zhonghua Yi Xue Za Zhi; 2014 Aug; 94(32):2485-9. PubMed ID: 25410917
[TBL] [Abstract][Full Text] [Related]
56. Pulmonary hypertensive vascular changes in lungs of patients with sudden unexpected death. Emphasis on congenital heart disease, Eisenmenger syndrome, postoperative deaths and death during pregnancy and postpartum.
Krexi D; Sheppard MN
J Clin Pathol; 2015 Jan; 68(1):18-21. PubMed ID: 25342758
[TBL] [Abstract][Full Text] [Related]
57. Pulmonary hypertension in adults with congenital heart disease and Eisenmenger syndrome: current advanced management strategies.
D'Alto M; Diller GP
Heart; 2014 Sep; 100(17):1322-8. PubMed ID: 24829371
[TBL] [Abstract][Full Text] [Related]
58. [Adults with congenital heart defects--clinical spectrum and surgical management].
Berdjis F; Brandl D; Uhlemann F; Hausdorf G; Lange L; Weng Y; Loebe M; Alexi V; Hetzer R; Lange PE
Herz; 1996 Oct; 21(5):330-6. PubMed ID: 9011542
[TBL] [Abstract][Full Text] [Related]
59. [Clinical features of adult patients with Eisenmenger syndrome associated with different types of congenital heart disease].
Chen G; He JG; Liu ZH; Gu Q; Ni XH; Zhao ZH; Xiong CM
Zhonghua Yi Xue Za Zhi; 2013 May; 93(20):1546-9. PubMed ID: 24028720
[TBL] [Abstract][Full Text] [Related]
60. Pulmonary arterial compliance is a useful predictor of pulmonary vascular disease in congenital heart disease.
Muneuchi J; Ochiai Y; Masaki N; Okada S; Iida C; Sugitani Y; Ando Y; Watanabe M
Heart Vessels; 2019 Mar; 34(3):470-476. PubMed ID: 30225809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
